| Deler fremragende | 10,376,109 shares |
| Insideraktier | 1.167.438 shares |
| Insider ejerskab | 11,25 % |
| Total Insiders | 32 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Brainstorm Cell Therapeutics Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| ACC International Holdings Ltd. - | 67.053 | 4.470 | |
| ACCBT Corp. | 3.181.925 | ||
| Irit Arbel Director - [D] | 41.054 | 41.054 | |
| Sankesh Abbhi Director - [D] | 11.323 | 755 | |
| June Sherie Almenoff Director - [D] | 6.000 | 400 | |
| Arturo Araya Chief Commercial Officer - [O] | 8.608 | 574 | |
| Menghisteab Bairu Director - [D] | 24.000 | 24.000 | |
| Yoram Bibring Chief Financial Officer - [O] | 50.000 | 3.333 | |
| Dagher Ibrahim B. Chief Medical Officer - [O] | 535.742 | 535.742 | |
| Jacob A Frenkel Director - [D] | 43.777 | 43.777 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Fiorino Anthony S. Chief Executive Officer - [O] | 2.500 | 167 | |
| Mordechai Friedman Director - [D] | 0 | 0 | |
| Hartoun Hartounian EVP, Chief Operating Officer - [O] | 52.000 | 52.000 | |
| Adrian Harel | 70.000 | ||
| Avi Israeli | 133.334 | ||
| Kern Ralph Dr. COO and Chief Medical Officer - [O] | 223.310 | 14.887 | |
| Chaim Lebovits President & CEO - [O] | 200.960 | 200.960 | |
| Stacy Lindborg Director - [D] | 48.229 | 48.229 | |
| Nir Naor Director - [D] | 31.465 | 31.465 | |
| Alla Patlis See Remarks - [O] | 44.349 | 44.349 | |
| Alon Pinkas | 15.333 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Polverino Anthony J. Director - [D] | 25.730 | 25.730 | |
| Eyal Rubin CFO and Treasurer - [O] | 25.000 | 1.667 | |
| Robert G L Shorr Director - [D] | 45.731 | 3.049 | |
| Chen Schor Director - [D] | 121.558 | 8.104 | |
| David Setboun EVP and COO - [O] | 55.000 | 3.667 | |
| Preetam Shah EVP, CFO and Treasurer - [O] | 11.600 | 773 | |
| Liat Sossover | 100.000 | ||
| Malcolm S Taub Director - [D] | 77.332 | 5.155 | |
| Kirk Taylor Chief Medical Officer - [O] | 35.000 | 2.333 | |
| Anthony Waclawski See Remarks - [O] | 35.000 | 2.333 | |
| Uri Yablonka EVP & Chief Business Officer, Director - [D] [O] | 68.464 | 68.464 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BCLI / Brainstorm Cell Therapeutics Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BCLI / Brainstorm Cell Therapeutics Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-07 | 2025-01-01 | 4 | Dagher Ibrahim B. | BCLI | Common Stock | D | 50.000 | 66.849 | ||||||
| 2025-01-07 | 3/A | Dagher Ibrahim B. | BCLI | Common Stock | D | 315.742 | ||||||||
| 2025-01-07 | 3/A | Dagher Ibrahim B. By the Reporting Person's Roth IRA | BCLI | Common Stock | I | 160.000 | ||||||||
| 2025-01-07 | 3/A | Dagher Ibrahim B. See Note | BCLI | Common Stock | I | 30.000 | ||||||||
| 2025-01-03 | 2025-01-01 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 120.000 | 200.960 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | FRENKEL JACOB A | BCLI | Common Stock | D | 40.000 | 43.777 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 24.000 | 25.730 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Yablonka Uri | BCLI | Common Stock | D | 20.000 | 68.464 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Yablonka Uri | BCLI | Common Stock | D | 40.000 | 48.464 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Naor Nir | BCLI | Common Stock | D | 30.666 | 31.465 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Patlis Alla | BCLI | Common Stock | D | 40.000 | 44.349 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | HARTOUNIAN HARTOUN | BCLI | Common Stock | D | 50.000 | 52.000 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 20.000 | 48.229 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Bairu Menghisteab | BCLI | Common Stock | D | 24.000 | 24.000 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 30.666 | 41.054 | ||||||
| 2024-10-02 | 2024-10-01 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 3,4272 | 1.836 | 6 | 80.960 | ||||
| 2024-10-02 | 2024-09-30 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,2280 | 22.000 | 5 | 1.186.865 | ||||
| 2024-07-31 | 2024-05-22 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,6400 | 25.000 | 16 | 1.149.865 | ||||
| 2024-07-31 | 2024-05-21 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,5790 | 25.000 | 14 | 1.124.865 | ||||
| 2024-07-31 | 2024-05-28 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,5183 | 15.000 | 8 | 1.164.865 | ||||
| 2024-07-31 | 2024-05-13 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,4900 | 10.000 | 5 | 1.099.865 | ||||
| 2024-07-31 | 2024-05-11 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,4665 | 10.000 | 5 | 1.089.865 | ||||
| 2024-07-31 | 2024-05-10 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,4650 | 20.000 | 9 | 1.079.865 | ||||
| 2024-07-31 | 2024-05-06 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,3753 | 135.000 | 51 | 993.565 | ||||
| 2024-07-31 | 2024-05-07 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,3743 | 66.300 | 25 | 1.059.865 | ||||
| 2024-07-31 | 2024-04-19 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,5199 | 15.000 | 8 | 858.565 | ||||
| 2024-07-31 | 2024-04-18 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,5255 | 115.072 | 60 | 843.565 | ||||
| 2024-07-31 | 2024-04-17 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0,5457 | 130.000 | 71 | 728.493 | ||||
| 2024-07-24 | 2024-07-19 | 4 | Dagher Ibrahim B. | BCLI | Common Stock | D | 0,3503 | -63.000 | -22 | 0 | ||||
| 2024-06-25 | 2024-06-24 | 4 | HARTOUNIAN HARTOUN | BCLI | Common Stock | D | 30.000 | 30.000 | ||||||
| 2024-06-03 | 2024-05-28 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,5183 | 15.000 | 8 | 1.164.865 | ||||
| 2024-05-23 | 2024-05-22 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,6400 | 25.000 | 16 | 1.149.865 | ||||
| 2024-05-23 | 2024-05-21 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,5790 | 25.000 | 14 | 1.124.865 | ||||
| 2024-05-14 | 2024-05-13 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,4900 | 10.000 | 5 | 1.099.865 | ||||
| 2024-05-14 | 2024-05-11 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,4665 | 10.000 | 5 | 1.089.865 | ||||
| 2024-05-14 | 2024-05-10 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,4650 | 20.000 | 9 | 1.079.865 | ||||
| 2024-05-07 | 2024-05-07 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,3743 | 66.300 | 25 | 1.059.865 | ||||
| 2024-05-07 | 2024-05-06 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,3753 | 135.000 | 51 | 993.565 | ||||
| 2024-04-25 | 2024-04-19 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,5199 | 15.000 | 8 | 858.565 | ||||
| 2024-04-22 | 3 | Dagher Ibrahim B. | BCLI | Common Stock | D | 63.000 | ||||||||
| 2024-04-22 | 3 | Dagher Ibrahim B. See Note | BCLI | Common Stock | I | 30.000 | ||||||||
| 2024-04-22 | 3 | Dagher Ibrahim B. By the Reporting Person's Roth IRA | BCLI | Common Stock | I | 160.000 | ||||||||
| 2024-04-19 | 2024-04-18 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,5255 | 115.072 | 60 | 843.565 | ||||
| 2024-04-19 | 2024-04-17 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0,5457 | 130.000 | 71 | 728.493 | ||||
| 2024-03-13 | 2024-03-11 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 241.935 | 423.435 | ||||||
| 2024-03-13 | 2024-03-11 | 4 | Yablonka Uri | BCLI | Common Stock | D | 109.426 | 126.969 | ||||||
| 2024-03-13 | 2024-03-11 | 4 | Patlis Alla | BCLI | Common Stock | D | 65.246 | 65.246 | ||||||
| 2024-03-13 | 2024-03-11 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 305.198 | 598.493 | ||||||
| 2023-09-05 | 2023-09-01 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 1,7741 | 11.500 | 20 | 181.500 | ||||
| 2023-08-07 | 2023-08-02 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 35.000 | 170.000 | ||||||
| 2023-08-04 | 2023-08-02 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31.185 | 293.295 | ||||||
| 2023-06-21 | 2023-06-19 | 4 | Naor Nir | BCLI | Common Stock | D | 11.999 | 11.999 | ||||||
| 2023-05-01 | 2023-05-01 | 4 | Taylor Kirk | BCLI | Common Stock | D | 35.000 | 35.000 | ||||||
| 2023-04-24 | 2023-04-20 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 75.000 | 262.110 | ||||||
| 2023-04-24 | 2023-04-20 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 75.000 | 135.000 | ||||||
| 2023-01-04 | 2022-12-07 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 35.000 | 60.000 | ||||||
| 2023-01-04 | 2022-09-18 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31.185 | 187.110 | ||||||
| 2022-04-08 | 2022-04-06 | 4 | FRENKEL JACOB A | BCLI | Stock Option (right to buy) | D | 0,75 | 50.000 | 50.000 | |||||
| 2022-03-14 | 2022-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35.885 | 223.310 | ||||||
| 2022-02-03 | 2022-02-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 3.882 | 25.960 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2.000 | 22.078 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12.000 | 77.332 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Almenoff June Sherie | BCLI | Common Stock | D | 2.000 | 6.000 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13.333 | 13.333 | |||||
| 2021-12-17 | 2021-12-15 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25.333 | 25.333 | |||||
| 2021-12-10 | 2021-12-10 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35.885 | 187.425 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12.000 | 65.332 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31.185 | 155.925 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2.000 | 20.078 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2.216 | 18.078 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25.333 | 25.333 | |||||
| 2021-12-10 | 2021-12-10 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13.333 | 13.333 | |||||
| 2021-12-10 | 2021-12-10 | 4 | Abbhi Sankesh | BCLI | Common Stock | D | 6.666 | 11.323 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | FRENKEL JACOB A | BCLI | Stock Option (right to buy) | D | 0,75 | 50.000 | 50.000 | |||||
| 2021-12-10 | 2021-12-10 | 4 | Almenoff June Sherie | BCLI | Common Stock | D | 2.000 | 4.000 | ||||||
| 2020-12-31 | 2020-12-30 | 4 | Shah Preetam | BCLI | Common Stock | D | 4,6400 | -25.000 | -116 | 11.600 | ||||
| 2020-11-19 | 2020-11-17 | 4 | Lindborg Stacy | BCLI | Call Option (right to buy) | D | 10,00 | 11.000,0000 | 200 | 2.200 | 200 | |||
| 2020-09-10 | 2020-09-08 | 4 | Waclawski Anthony | BCLI | Stock Option (Right to Buy) | D | 12,58 | 80.000 | 80.000 | |||||
| 2020-09-10 | 2020-09-08 | 4 | Waclawski Anthony | BCLI | Common Stock | D | 35.000 | 35.000 | ||||||
| 2020-07-31 | 2020-07-26 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31.185 | 124.740 | ||||||
| 2020-07-16 | 2020-07-15 | 4 | Abbhi Sankesh Abbhi Investments, LLC | BCLI | Common Stock | I | 12,9900 | 46.779 | 608 | 2.164.530 | ||||
| 2020-07-16 | 2020-07-16 | 4 | Setboun David | BCLI | Common Stock | D | 12,9480 | 5.000 | 65 | 55.000 | ||||
| 2020-07-16 | 2020-07-16 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13,4668 | -7.823 | -105 | 67.053 | ||||
| 2020-07-16 | 2020-07-15 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13,1153 | -18.430 | -242 | 74.876 | ||||
| 2020-07-16 | 2020-07-13 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13,5238 | -40.000 | -541 | 93.306 | ||||
| 2020-07-16 | 2020-07-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13,3500 | -2.000 | -27 | 133.306 | ||||
| 2020-07-16 | 2020-07-09 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13,1253 | -3.500 | -46 | 135.306 | ||||
| 2020-06-26 | 2020-06-23 | 4 | Yablonka Uri | BCLI | Common Stock | D | 10.000 | 17.543 | ||||||
| 2020-06-01 | 2020-06-01 | 4 | Lindborg Stacy | BCLI | Stock Option (right to buy) | D | 7,67 | 100.000 | 100.000 | |||||
| 2020-06-01 | 2020-06-01 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 25.000 | 25.000 | ||||||
| 2020-04-07 | 2020-04-06 | 4 | FRENKEL JACOB A | BCLI | Stock Option (right to buy) | D | 0,75 | 50.000 | 50.000 | |||||
| 2020-04-07 | 2020-04-07 | 4 | Setboun David | BCLI | Common Stock | D | 50.000 | 50.000 | ||||||
| 2020-04-07 | 3 | Abbhi Sankesh Abbhi Investments, LLC | BCLI | Common Stock | I | 4.235.502 | ||||||||
| 2020-04-07 | 3 | Abbhi Sankesh Abbhi Investments, LLC | BCLI | Common Stock | I | 4.235.502 | ||||||||
| 2020-04-07 | 3 | Abbhi Sankesh Abbhi Investments, LLC | BCLI | Common Stock | I | 4.235.502 | ||||||||
| 2020-04-07 | 2020-04-06 | 4 | Abbhi Sankesh | BCLI | Common Stock | D | 4.657 | 4.657 | ||||||
| 2020-04-07 | 3 | FRENKEL JACOB A | BCLI | Common Stock | D | 113.334 | ||||||||
| 2020-04-07 | 3 | FRENKEL JACOB A | BCLI | Common Stock | D | 113.334 | ||||||||
| 2020-04-07 | 3 | FRENKEL JACOB A | BCLI | Common Stock | D | 113.334 | ||||||||
| 2020-03-13 | 2020-03-09 | 4 | Kern Ralph Dr. | BCLI | Stock Option (right to buy) | D | 7,33 | 80.000 | 80.000 | |||||
| 2020-03-06 | 2020-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35.885 | 151.540 | ||||||
| 2020-02-14 | 2019-12-12 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25.333 | 25.333 | |||||
| 2020-02-14 | 2019-12-12 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12.000 | 53.332 | ||||||
| 2020-02-14 | 2019-12-12 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13.333 | 13.333 | |||||
| 2020-02-14 | 2019-12-12 | 4 | Almenoff June Sherie | BCLI | Common Stock | D | 2.000 | 2.000 | ||||||
| 2020-02-14 | 2020-02-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 3.071 | 15.862 | ||||||
| 2020-02-14 | 2019-12-12 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2.000 | 12.791 | ||||||
| 2019-12-27 | 2019-12-24 | 4 | Araya Arturo | BCLI | Common Stock | D | 3,9000 | 3.000 | 12 | 8.608 | ||||
| 2019-12-27 | 2019-12-24 | 4 | Shah Preetam | BCLI | Common Stock | D | 3,9594 | 11.600 | 46 | 36.600 | ||||
| 2019-12-27 | 2019-12-24 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 3,8800 | 3.000 | 12 | 115.655 | ||||
| 2019-09-09 | 2019-09-06 | 4 | Shah Preetam | BCLI | Stock Option (right to buy) | D | 3,96 | 100.000 | 100.000 | |||||
| 2019-09-09 | 2019-09-06 | 4 | Shah Preetam | BCLI | Stock Option (right to buy) | D | 6,00 | 100.000 | 100.000 | |||||
| 2019-09-09 | 2019-09-06 | 4 | Shah Preetam | BCLI | Common Stock | D | 25.000 | 25.000 | ||||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 2,25 | -6.666 | 0 | |||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 2,25 | -6.666 | 0 | |||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 3,6672 | -13.332 | -49 | 155.833 | ||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 2,2500 | 6.666 | 15 | 169.165 | ||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 2,2500 | 6.666 | 15 | 169.165 | ||||
| 2019-07-26 | 2019-07-26 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31.185 | 2.166.155 | ||||||
| 2019-03-08 | 2019-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35.885 | 112.655 | ||||||
| 2019-02-22 | 2019-02-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 3.501 | 10.791 | ||||||
| 2019-01-08 | 2019-01-04 | 4 | Almenoff June Sherie By Meadowlark Management LLC | BCLI | Common Stock | I | 3,3900 | 1.475 | 5 | 7.175 | ||||
| 2018-12-21 | 2018-10-24 | 4 | Schor Chen By The C. Schor Irrevocable Trust | BCLI | Common Stock | I | 121.558 | 121.558 | ||||||
| 2018-12-21 | 2018-10-24 | 4 | Schor Chen | BCLI | Common Stock | D | -121.558 | 4.000 | ||||||
| 2018-11-30 | 2018-11-30 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12.000 | 41.332 | ||||||
| 2018-11-30 | 2018-11-30 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13.333 | 13.333 | |||||
| 2018-11-30 | 2018-11-30 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25.333 | 25.333 | |||||
| 2018-11-30 | 2018-11-30 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 1.667 | 7.290 | ||||||
| 2018-11-30 | 2018-11-30 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2.000 | 5.623 | ||||||
| 2018-11-30 | 2018-11-30 | 4 | Schor Chen | BCLI | Common Stock | D | 2.000 | 125.558 | ||||||
| 2018-09-04 | 2018-08-28 | 4 | Araya Arturo | BCLI | Stock Option (right to buy) | D | 3,98 | 200.000 | 200.000 | |||||
| 2018-09-04 | 2018-08-28 | 4 | Araya Arturo | BCLI | Common Stock | D | -2.805 | 5.608 | ||||||
| 2018-07-27 | 2018-07-26 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31.185 | 2.134.970 | ||||||
| 2018-03-26 | 2018-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35.885 | 76.770 | ||||||
| 2018-03-26 | 2018-03-26 | 4 | Araya Arturo | BCLI | Common Stock | D | 1.249 | 8.413 | ||||||
| 2018-03-20 | 2018-03-15 | 4/A | Kern Ralph Dr. | BCLI | Common Stock | D | 3,5994 | 5.000 | 18 | 40.885 | ||||
| 2018-03-20 | 2018-03-15 | 4/A | Almenoff June Sherie By Meadowlark Management LLC | BCLI | Common Stock | I | 3,5000 | 5.700 | 20 | 5.700 | ||||
| 2018-03-19 | 2018-03-15 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 3,5994 | 5.000 | 18 | 40.885 | ||||
| 2018-03-16 | 2018-03-15 | 4 | Almenoff June Sherie By Meadowlark Management LLC | BCLI | Common Stock | I | 3,5000 | 5.700 | 20 | 5.700 | ||||
| 2018-02-28 | 2018-02-26 | 4 | Araya Arturo | BCLI | Common Stock | D | 4.152 | 7.164 | ||||||
| 2018-02-05 | 2018-02-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 3.623 | 3.623 | ||||||
| 2017-11-20 | 2017-11-20 | 4 | Rubin Eyal | BCLI | Stock Option (right to buy) | D | 4,30 | 93.686 | 93.686 | |||||
| 2017-11-20 | 2017-11-20 | 4 | Rubin Eyal | BCLI | Common Stock | D | 25.000 | 25.000 | ||||||
| 2017-11-13 | 2017-11-10 | 4 | Schor Chen | BCLI | Common Stock | D | 2.000 | 123.558 | ||||||
| 2017-11-13 | 2017-11-10 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12.000 | 29.332 | ||||||
| 2017-11-13 | 2017-11-10 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13.333 | 13.333 | |||||
| 2017-11-13 | 2017-11-10 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25.333 | 25.333 | |||||
| 2017-11-13 | 2017-11-10 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 8.666 | 45.731 | ||||||
| 2017-08-31 | 2017-08-31 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 4,2600 | 2.500 | 11 | 155.833 | ||||
| 2017-08-23 | 2017-08-23 | 4 | Yablonka Uri | BCLI | Common Stock | D | 3,9800 | 2.000 | 8 | 7.543 | ||||
| 2017-07-26 | 2017-07-26 | 4 | Lebovits Chaim | BCLI | Stock Option (right to buy) | D | 4,81 | 41.580 | 41.580 | |||||
| 2017-07-26 | 2017-07-26 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31.185 | 2.103.785 | ||||||
| 2017-07-17 | 2017-07-13 | 4 | Yablonka Uri | BCLI | Common Stock | D | 5.543 | 5.543 | ||||||
| 2017-07-17 | 2017-07-13 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 12.000 | 12.000 | |||||
| 2017-03-06 | 2017-03-06 | 4 | Kern Ralph Dr. | BCLI | Stock Option (right to buy) | D | 4,18 | 47.847 | 47.847 | |||||
| 2017-03-06 | 2017-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35.885 | 35.885 | ||||||
| 2017-03-03 | 2017-02-26 | 4 | Araya Arturo | BCLI | Common Stock | D | 3.012 | 3.012 | ||||||
| 2017-02-28 | 2017-02-26 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 6.667 | 6.667 | |||||
| 2016-06-23 | 2016-06-22 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 8.666 | 37.065 | ||||||
| 2016-06-23 | 2016-06-22 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25.333 | 25.333 | |||||
| 2016-06-23 | 2016-06-22 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 8.666 | 17.332 | ||||||
| 2016-06-23 | 2016-06-22 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0,75 | 15.333 | 15.333 | |||||
| 2016-06-23 | 2016-06-22 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0,75 | 16.666 | 16.666 | |||||
| 2016-06-23 | 2016-06-22 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13.333 | 13.333 | |||||
| 2015-12-17 | 2015-12-16 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 2,7100 | -10.800 | -29 | 28.399 | ||||
| 2015-12-16 | 2015-12-14 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0,75 | -5.000 | 11.666 | |||||
| 2015-12-16 | 2015-12-14 | 4 | Friedman Mordechai | BCLI | Common Stock | D | 2,5700 | -5.000 | -13 | 0 | ||||
| 2015-12-16 | 2015-12-14 | 4 | Friedman Mordechai | BCLI | Common Stock | D | 0,7500 | 5.000 | 4 | 5.000 | ||||
| 2015-12-16 | 2015-12-15 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 2,5900 | -11.263 | -29 | 8.666 | ||||
| 2015-12-16 | 2015-12-14 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 2,6100 | -30.479 | -80 | 19.929 | ||||
| 2015-12-14 | 2015-12-11 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 2,6600 | -980 | -3 | 50.408 | ||||
| 2015-12-14 | 2015-12-10 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 2,7400 | -12.500 | -34 | 51.388 | ||||
| 2015-12-14 | 2015-12-11 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 2,5600 | -5.300 | -14 | 39.199 | ||||
| 2015-12-14 | 2015-12-10 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 2,7100 | -5.500 | -15 | 44.499 | ||||
| 2015-12-03 | 2015-12-01 | 4 | Bibring Yoram | BCLI | Stock Option (right to buy) | D | 3,17 | 82.500 | 82.500 | |||||
| 2015-10-13 | 2015-09-28 | 4/A | Lebovits Chaim | BCLI | Stock Option (right to buy) | D | 2,45 | 369.619 | 369.619 | |||||
| 2015-10-02 | 2015-10-01 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 2,5800 | 2.000 | 5 | 138.806 | ||||
| 2015-10-01 | 2015-09-28 | 4 | Lebovits Chaim | BCLI | Stock Option (right to buy) | D | 2,45 | 369.619 | 369.619 | |||||
| 2015-10-01 | 2015-09-30 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 2,3400 | 9.200 | 22 | 136.806 | ||||
| 2015-08-31 | 2015-08-27 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 8.666 | 49.999 | ||||||
| 2015-08-31 | 2015-08-27 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,75 | 13.333 | 13.333 | |||||
| 2015-08-31 | 2015-08-27 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 8.666 | 50.554 | ||||||
| 2015-08-31 | 2015-08-27 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0,75 | 15.333 | 15.333 | |||||
| 2015-08-31 | 2015-08-27 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0,75 | 16.666 | 16.666 | |||||
| 2015-08-31 | 2015-08-27 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 25.333 | 25.333 | |||||
| 2015-08-21 | 2015-08-20 | 4 | Bibring Yoram | BCLI | Common Stock | D | 3,0400 | 8.500 | 26 | 50.000 | ||||
| 2015-08-19 | 2015-08-17 | 4 | Bibring Yoram | BCLI | Common Stock | D | 2,9200 | 41.500 | 121 | 41.500 | ||||
| 2015-08-03 | 2015-07-30 | 4 | Bibring Yoram | BCLI | Stock Option (right to buy) | D | 3,17 | 165.000 | 165.000 | |||||
| 2015-06-03 | 2015-06-01 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,75 | 6.667 | 6.667 | |||||
| 2015-05-05 | 2015-05-03 | 4 | Schor Chen | BCLI | Common Stock | D | 60.000 | 121.558 | ||||||
| 2014-10-15 | 2014-10-15 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 3,5990 | 300 | 1 | 2.500 | ||||
| 2014-10-15 | 2014-10-15 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 3,5900 | 200 | 1 | 2.200 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9999 | 300 | 1 | 127.606 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9499 | 700 | 3 | 127.306 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9500 | 300 | 1 | 126.606 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0100 | 400 | 2 | 126.306 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9799 | 400 | 2 | 125.906 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9799 | 1.300 | 5 | 125.506 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0099 | 600 | 2 | 124.206 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0399 | 600 | 2 | 123.606 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0500 | 300 | 1 | 123.006 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0799 | 200 | 1 | 122.706 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0899 | 2.500 | 10 | 122.506 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2900 | 1.000 | 4 | 120.006 | ||||
| 2014-10-01 | 2014-10-01 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0799 | 3.600 | 15 | 119.006 | ||||
| 2014-10-01 | 2014-09-30 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,3200 | 1.000 | 4 | 115.406 | ||||
| 2014-10-01 | 2014-09-30 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2150 | 500 | 2 | 114.406 | ||||
| 2014-10-01 | 2014-09-29 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,1200 | 1.000 | 4 | 113.906 | ||||
| 2014-10-01 | 2014-09-29 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,1700 | 500 | 2 | 112.906 | ||||
| 2014-10-01 | 2014-09-29 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,1800 | 100 | 0 | 112.406 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,3000 | 1.800 | 8 | 112.306 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2900 | 2.000 | 9 | 110.506 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2800 | 400 | 2 | 108.506 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2700 | 1.000 | 4 | 108.106 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2300 | 1.200 | 5 | 107.106 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,2000 | 500 | 2 | 105.906 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,1800 | 300 | 1 | 105.406 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,1400 | 500 | 2 | 105.106 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,1000 | 300 | 1 | 104.606 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4,0500 | 500 | 2 | 104.306 | ||||
| 2014-09-24 | 2014-09-19 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9400 | 1.000 | 4 | 103.806 | ||||
| 2014-09-24 | 2014-09-19 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3,9000 | 1.500 | 6 | 102.806 | ||||
| 2014-09-19 | 2014-09-18 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 3,8400 | 800 | 3 | 2.000 | ||||
| 2014-09-16 | 2014-09-15 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 0,2835 | 3.000 | 1 | 18.000 | ||||
| 2014-09-16 | 2014-09-15 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 0,2875 | 5.000 | 1 | 15.000 | ||||
| 2014-09-16 | 2014-09-12 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 0,2850 | 7.500 | 2 | 10.000 | ||||
| 2014-09-16 | 2014-09-12 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 0,2800 | 2.500 | 1 | 2.500 | ||||
| 2014-08-19 | 2014-08-15 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 130.000 | 620.000 | ||||||
| 2014-08-19 | 2014-08-15 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,05 | 380.000 | 380.000 | |||||
| 2014-08-19 | 2014-08-15 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 130.000 | 628.333 | ||||||
| 2014-08-19 | 2014-08-15 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0,05 | 230.000 | 230.000 | |||||
| 2014-08-19 | 2014-08-15 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0,05 | 250.000 | 250.000 | |||||
| 2014-08-19 | 2014-08-15 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,05 | 200.000 | 200.000 | |||||
| 2014-06-20 | 2014-06-16 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 0,2900 | 130.000 | 38 | 1.519.600 | ||||
| 2014-06-16 | 2014-06-13 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 0,3500 | 150.000 | 52 | 1.389.600 | ||||
| 2014-06-10 | 2014-06-09 | 4 | Fiorino Anthony S. | BCLI | Stock Option (right to buy) | D | 0,30 | 5.700.000 | 5.700.000 | |||||
| 2014-06-09 | 2014-06-06 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0,18 | 500.000 | 500.000 | |||||
| 2014-05-02 | 2014-04-28 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 0,3000 | 939.600 | 282 | 1.239.600 | ||||
| 2014-04-14 | 2014-04-13 | 4 | Israeli Avi | BCLI | Stock Option (right to buy) | D | 133.334 | 133.334 | ||||||
| 2014-04-14 | 2014-04-13 | 4 | Israeli Avi | BCLI | Stock Option (right to buy) | D | 166.666 | 166.666 | ||||||
| 2014-01-03 | 2013-12-31 | 4 | Sossover Liat | BCLI | Stock Option (right to buy) | D | 0,18 | 100.000 | 100.000 | |||||
| 2013-04-23 | 2013-04-19 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 130.000 | 490.000 | ||||||
| 2013-04-23 | 2013-04-19 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,15 | 180.000 | 180.000 | |||||
| 2013-04-23 | 2013-04-19 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 130.000 | 498.333 | ||||||
| 2013-04-23 | 2013-04-13 | 4 | Israeli Avi | BCLI | Stock Option (right to buy) | D | 166.666 | 166.666 | ||||||
| 2013-04-23 | 2013-04-19 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0,15 | 130.000 | 130.000 | |||||
| 2013-04-23 | 2013-04-19 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0,15 | 150.000 | 150.000 | |||||
| 2012-09-06 | 2012-08-01 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0,15 | 180.000 | 180.000 | |||||
| 2012-09-06 | 2012-08-01 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0,15 | 130.000 | 130.000 | |||||
| 2012-09-06 | 2012-08-01 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0,15 | 150.000 | 150.000 | |||||
| 2012-08-27 | 2012-08-01 | 4/A | Harel Adrian | BCLI | Stock Option (right to buy) | D | 0,26 | 70.000 | 70.000 | |||||
| 2012-08-27 | 2012-08-01 | 4/A | Sossover Liat | BCLI | Stock Option (right to buy) | D | 0,26 | 60.000 | 60.000 | |||||
| 2012-08-03 | 2012-08-01 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 130.000 | 360.000 | ||||||
| 2012-08-03 | 2012-08-01 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 130.000 | 368.333 | ||||||
| 2012-08-03 | 2012-08-01 | 4 | Sossover Liat | BCLI | Stock Option (right to buy) | D | 0,26 | 60.000 | 60.000 | |||||
| 2012-08-03 | 2012-08-01 | 4 | Harel Adrian | BCLI | Stock Option (right to buy) | D | 0,26 | 70.000 | 70.000 | |||||
| 2012-04-17 | 2012-04-13 | 4 | Israeli Avi | BCLI | Stock Option (right to buy) | D | 166.666 | 166.666 | ||||||
| 2009-04-03 | 3 | TAUB MALCOLM S | BCLI | Common Stock | D | 1.250.000 | ||||||||
| 2007-08-08 | 2007-08-02 | 4 | ACCBT Corp. | BCLI | Right to Acquire Warrant to Purchase Common Stock | D | 636.385,00 | 3.181.925 | 3.181.925 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
